89 related articles for article (PubMed ID: 11564549)
1. Investigation of Smith's quinolone killing mechanisms during the PAE of ciprofloxacin on Escherichia coli.
Wickens HJ; Pinney RJ
Int J Pharm; 2001 Oct; 227(1-2):149-56. PubMed ID: 11564549
[TBL] [Abstract][Full Text] [Related]
2. Flow cytometric investigation of filamentation, membrane patency, and membrane potential in Escherichia coli following ciprofloxacin exposure.
Wickens HJ; Pinney RJ; Mason DJ; Gant VA
Antimicrob Agents Chemother; 2000 Mar; 44(3):682-7. PubMed ID: 10681338
[TBL] [Abstract][Full Text] [Related]
3. Bactericidal activity of ciprofloxacin upon Escherichia coli and Acinetobacter baumanni.
Zemelman R; Vejar C; Bello H; Domínguez M; González G
Rev Latinoam Microbiol; 1992; 34(4):245-8. PubMed ID: 1345113
[TBL] [Abstract][Full Text] [Related]
4. Antagonism between bactericidal activities of 4-quinolones and coumarins gives insight into 4-quinolone killing mechanisms.
Howard BM; Pinney RJ; Smith JT
Microbios; 1994; 77(311):121-31. PubMed ID: 8152392
[TBL] [Abstract][Full Text] [Related]
5. 4-Quinolone bactericidal mechanisms.
Howard BM; Pinney RJ; Smith JT
Arzneimittelforschung; 1993 Oct; 43(10):1125-9. PubMed ID: 7505585
[TBL] [Abstract][Full Text] [Related]
6. Conditions required for the bactericidal activity of fleroxacin and pefloxacin against Escherichia coli KL 16.
Lewin CS; Amyes SG
J Med Microbiol; 1990 Jun; 32(2):83-6. PubMed ID: 1693968
[TBL] [Abstract][Full Text] [Related]
7. Effect of anaerobic growth on quinolone lethality with Escherichia coli.
Malik M; Hussain S; Drlica K
Antimicrob Agents Chemother; 2007 Jan; 51(1):28-34. PubMed ID: 17043118
[TBL] [Abstract][Full Text] [Related]
8. Determination of the in vivo post-antibiotic effects of ciprofloxacin and rifampicin.
Meng X; Pei Y; Nightingale CH; Quintiliani R
J Antimicrob Chemother; 1995 Dec; 36(6):987-96. PubMed ID: 8821597
[TBL] [Abstract][Full Text] [Related]
9. Analysis of macromolecular biosynthesis to define the quinolone-induced postantibiotic effect in Escherichia coli.
Guan L; Blumenthal RM; Burnham JC
Antimicrob Agents Chemother; 1992 Oct; 36(10):2118-24. PubMed ID: 1280055
[TBL] [Abstract][Full Text] [Related]
10. Loss of bactericidal activities of quinolones during the post-antibiotic effect induced by rifampicin.
Meng X; Nightingale CH; Sweeney KR; Quintiliani R
J Antimicrob Chemother; 1994 Apr; 33(4):721-8. PubMed ID: 8056690
[TBL] [Abstract][Full Text] [Related]
11. DNA gyrase and topoisomerase IV on the bacterial chromosome: quinolone-induced DNA cleavage.
Chen CR; Malik M; Snyder M; Drlica K
J Mol Biol; 1996 May; 258(4):627-37. PubMed ID: 8636997
[TBL] [Abstract][Full Text] [Related]
12. Protein- and RNA-synthesis independent bactericidal activity of ciprofloxacin that involves the A subunit of DNA gyrase.
Lewin CS; Howard BM; Smith JT
J Med Microbiol; 1991 Jan; 34(1):19-22. PubMed ID: 1703579
[TBL] [Abstract][Full Text] [Related]
13. Identification of a pKM101 region which confers a slow growth rate and interferes with susceptibility to quinolone in Escherichia coli AB1157.
Clerch B; Rivera E; Llagostera M
J Bacteriol; 1996 Oct; 178(19):5568-72. PubMed ID: 8824598
[TBL] [Abstract][Full Text] [Related]
14. Sitafloxacin (DU-6859a) and trovafloxacin: postantibiotic effect and in vitro interactions with rifampin on methicillin-resistant Staphylococcus aureus.
Giamarellou-Bourboulis EJ; Sambatakou H; Grecka P; Chryssouli Z; Giamarellou H
Diagn Microbiol Infect Dis; 1999 Aug; 34(4):301-7. PubMed ID: 10459481
[TBL] [Abstract][Full Text] [Related]
15. Performance of the fractional maximal effect method: comparative interaction studies of ciprofloxacin and protein synthesis inhibitors.
Li RC; Nix DE; Schentag JJ
J Chemother; 1996 Feb; 8(1):25-32. PubMed ID: 8835104
[TBL] [Abstract][Full Text] [Related]
16. [Investigation of the effect of efflux pump inhibitors to MIC values of ciprofloxacin in clinical isolates of Pseudomonas aeruginosa, Escherichia coli, Acinetobacter baumannii and Staphylococcus aureus].
Cetinkaya E; Coban AY; Durupinar B
Mikrobiyol Bul; 2008 Oct; 42(4):553-61. PubMed ID: 19149076
[TBL] [Abstract][Full Text] [Related]
17. Bactericidal mechanisms of ofloxacin.
Lewin CS; Smith JT
J Antimicrob Chemother; 1988 Sep; 22 Suppl C():1-8. PubMed ID: 3053574
[TBL] [Abstract][Full Text] [Related]
18. Postantibiotic effect of CI-960, enoxacin and ciprofloxacin on Escherichia coli: effect on morphology and haemolysin activity.
Guan L; Burnham JC
J Antimicrob Chemother; 1992 May; 29(5):529-38. PubMed ID: 1320604
[TBL] [Abstract][Full Text] [Related]
19. Rapid assessment of the effect of ciprofloxacin on chromosomal DNA from Escherichia coli using an in situ DNA fragmentation assay.
Tamayo M; Santiso R; Gosalvez J; Bou G; Fernández JL
BMC Microbiol; 2009 Apr; 9():69. PubMed ID: 19364397
[TBL] [Abstract][Full Text] [Related]
20. Postantibiotic effect of ciprofloxacin compared with that of five other quinolones.
Minguez F; Ramos C; Barrientos S; Loscos A; Prieto J
Chemotherapy; 1991; 37(6):420-5. PubMed ID: 1760941
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
